Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 4059-4066

  Shao, Jian Yong ^a   Zhang, Yu ^a   Li, Yu Hong ^a   Gao, Hong Yi ^a   Feng, Hui Xia ^a   Wu, Qiu Liang ^a   Cui, Nian Ji ^a   Cheng, Gang ^b   Hu, Bin ^b   Hu, Li Fu ^c   Ernberg, Ingemar ^c   Zeng, Yi Xin ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Epstein Barr virus; Nasopharyngeal carcinoma; Real time PCR

Indexed keywords

BIOLOGICAL MARKER; VIRUS DNA; EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 1; VIRUS RNA;

ARTICLE; BLOOD CELL; CANCER CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DNA DETERMINATION; EBER1 GENE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PLASMA CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; RHINOPHARYNGITIS; SENSITIVITY ANALYSIS; VIRUS GENE; VIRUS LOAD; BLOOD; CANCER STAGING; GENETICS; IN SITU HYBRIDIZATION; METABOLISM; METHODOLOGY; NASOPHARYNX TUMOR; PATHOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIROLOGY; VIRUS INFECTION;

DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 20144387079     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K and Raab-Traub N: Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 146: 1355-6137, 1995.
2. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K and Raffeld M: Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 88: 242-51, 1996.
3. Ablashi DV, Levine PH, Prasad U and Pearson GR: Fourth International Symposium on nasopharyngeal carcinoma application of field and laboratory studies to the control of NPC. Cancer Res 43: 2375-2378, 1983.
4. Feng BJ, Huang W, Shugart YY, Lee MK, Zhang F, Xia JC, Wang HY, Huang TB, Jian SW, Huang P, Feng QS, Huang LX, Yu XJ, Li D, Chen LZ, Jia WH, Fang Y, Huang HM, Zhu JL, Liu XM, Zhao Y, Liu WQ, Deng MQ, Hu WH, Wu SX, Mo HY, Hong MF, King MC, Chen Z and Zeng YX: Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 31: 395-399, 2002.
5. Shao JY, Wang HY, Huang XM, Feng QS, Huang P, Feng BJ, Huang LX, Yu XJ, Li JT, Hu LF, Ernberg I and Zeng YX: Genome-wide alleotype analysis of sporadic primary nasopharyngeal carcinoma from Southern China. Int J Oncol 17: 1267-1275, 2000.
6. Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, Hu LF and Zeng YX: Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Anticancer Res 21(4B): 3021-3029, 2001.
7. Mutirangura A, Pornthanakasem W, Theamboonlers A, Sriuranpong V, Lertsanguansinchi P, Yenrudi S, Voravud N, Supiyaphun P and Poovorawan Y: Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res 4: 665-669, 1998.
8. Shotelersuk K, Khorprasert C, Sakdikul S, Pornthanakasem W, Voravud N and Mutirangura A: Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin Cancer Res 6: 1046-1051, 2000.
9. Lo YM, Chan AT, Chan LY, Leung SF, Lam CW, Huang DP and Johnson PJ: Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res 60: 6878-6881, 2000.
10. Lo YM, Chan LY, Chan AT, Leung SF, Lo KW, Zhang J, Lee JC, Hjelm NM, Johnson PJ and Huang DP: Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 59: 5452-5455, 1999.
11. Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M, Ho S, Huang DP and Johnson PJ: Plasma Epstein-Barr DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Nat Cancer Inst 94: 1614-1619, 2002.
12. Lin JC, Chen KY, Wang WY, Jan JS, Liang WM, Tsai CS and Wei YH: Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival. J Clin Oncol 19: 2607-2615, 2001.
13. Min HQ, Hong MH, Ma J, Zhang EP, Zheng QX, Zhang J, Zhang JM, Zhang F, Su Y and Qiu F: A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Biol Phys 30: 1037-1044, 1994.
14. Hong MH, Mai HQ, Min HQ, Ma J, Zhang EP and Cui NJ: A comparison of the Chinese 1992 and fifth-edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma. Cancer 89: 242-247, 2000.
15. Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I and Zeng YX: Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer 100: 1162-1170, 2004.
16. Gibson UE, Heid CA and Williams PM: A novel method for real time quantitative RT-PCR. Genome Res 6: 995-1001, 1996.
17. Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, Poon PMK, Wainscoat JS, Johnson PJ, Chang AMZ and Hjelm NM: Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62: 768-775, 1998.
18. Tsai ST, Jin YT and Su IJ: Expression of EBER1 in primary and metastatic NPC tissues uing in situ hybridization. A correlation with WHO histologic sub-types. Cancer 77: 231-236, 1996.
19. Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C and Beljinski M: Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46: 318-322, 1989.
20. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, Lederrey C and Anker P: Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2: 1033-1035, 1996.
21. Nawroz H, Koch W, Anker P, Stroun M and Sidransky D: Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2: 1035-1037, 1996.
22. Lo YM, Chan LY, Lo KW, Leung SF, Zhang J, Chan AT, Lee JC, Hjelm NM, Johnson PJ and Huang DP: Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 59: 1188-1191, 1999.
23. Lo YM, Leung SF, Chan LY, Chan AT, Lo KW, Johnson PJ and Huang DP: Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res 60: 2351-2355, 2000.
24. Livak KJ, Flood SJ, Marmaro J, Giusti W and Deetz K: Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 4: 357-362, 1995.
25. Holland PM, Abramson RD, Watson R and Gelfand DH: Detection of specific polymerase chain reaction product by utilizing the 5'-3' exonuclease activity of the Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 88: 7276-7280, 1991.
26. Lee WY, Hsiao JR, Jin YT and Tsai ST: Epstein-Barr virus detection in neck metastases by in-situ hybridization in fine-needle aspiration cytologic studies: an aid for differentiating the primary site. Head Neck 22: 336-40, 2000.
27. Vera-Sempere F, Burgos J, Botella MS and Morera C: Comparative analysis of Epstein-Barr virus (EBV) detection by nested-PCR and non-isotopic in situ hybridization in nasopharyngeal carcinoma (NPC). Clin Chim Acta 271: 119-32, 1998.